These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Optimizing the use of abciximab and intracoronary stents in patients with acute ST elevation myocardial infarction. Velianou JL; Al-Suwaidi J; Mathew V Am J Cardiovasc Drugs; 2002; 2(5):315-22. PubMed ID: 14727961 [TBL] [Abstract][Full Text] [Related]
44. Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. Mukherjee D; Topol EJ; Bertrand ME; Kristensen SD; Herrmann HC; Neumann FJ; Yakubov SJ; Bassand JP; McClure RR; Stone GW; Ardissino D; Moliterno DJ; Eur Heart J; 2005 Dec; 26(23):2524-8. PubMed ID: 16107485 [TBL] [Abstract][Full Text] [Related]
46. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial. Greenbaum AB; Grines CL; Bittl JA; Becker RC; Kereiakes DJ; Gilchrist IC; Clegg J; Stankowski JE; Grogan DR; Harrington RA; Emanuelsson H; Weaver WD Am Heart J; 2006 Mar; 151(3):689.e1-689.e10. PubMed ID: 16504633 [TBL] [Abstract][Full Text] [Related]
47. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results. Popma JJ; Satler LF J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090 [TBL] [Abstract][Full Text] [Related]
48. [The initial experience of the use of ReoPro in high-risk coronary angioplasty in Italy: the Italian Registry on the Conditions for the Use of ReoPro during Angioplasty (R.I.CO.R.D.A.)]. Simonetti I; Gallopin M; Klugmann S; Gensini GF Ital Heart J Suppl; 2000 Jan; 1(1):88-96. PubMed ID: 10832124 [TBL] [Abstract][Full Text] [Related]
49. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?). Kalyanasundaram A; Blankenship JC; Berger P; Herrmann H; McClure R; Moliterno D Catheter Cardiovasc Interv; 2007 Apr; 69(5):623-9. PubMed ID: 17192960 [TBL] [Abstract][Full Text] [Related]
50. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty. Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156 [TBL] [Abstract][Full Text] [Related]
51. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843 [TBL] [Abstract][Full Text] [Related]
52. Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation. Velianou JL; Mathew V; Wilson SH; Barsness GW; Grill DE; Holmes DR Am J Cardiol; 2000 Nov; 86(10):1063-8. PubMed ID: 11074200 [TBL] [Abstract][Full Text] [Related]
53. One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study. Bertrand OF; Rodés-Cabau J; Larose E; Nguyen CM; Roy L; Déry JP; Courtis J; Nault I; Poirier P; Costerousse O; De Larochellière R Am Heart J; 2008 Jul; 156(1):135-40. PubMed ID: 18585508 [TBL] [Abstract][Full Text] [Related]
54. Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial. Mehilli J; Ndrepepa G; Kastrati A; Neumann FJ; ten Berg J; Bruskina O; Dotzer F; Seyfarth M; Pache J; Kufner S; Dirschinger J; Berger PB; Schömig A Am Heart J; 2007 Jul; 154(1):158.e1-7. PubMed ID: 17584569 [TBL] [Abstract][Full Text] [Related]